| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 109,535 | 96,552 | 97,376 | 116,253 | | Cost of Revenue | 49,087 | 20,374 | 77,472 | 93,107 | | | Gross Profit | 60,448 | 76,178 | 19,904 | 23,146 | | | Operating Expenses | | Research Development |
-
| 75,262 |
-
|
-
| | Selling General and Administrative | 11,034 | 10,916 | 12,446 | 11,030 | | Non Recurring | 119,576 | 3,288 | (36,800) | (15,246) | | Others | 75,980 | 73,970 | 93,397 | 326,734 | | | | Total Operating Expenses |
-
| 163,436 |
-
|
-
| | | | Operating Income or Loss | (35,514) | (87,258) | (49,139) | (299,372) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 35,664 | 2,843 | 329 | (244) | | Earnings Before Interest And Taxes | (67,087) | (84,415) | (48,810) | (299,616) | | Interest Expense | (20,941) | 10,275 | 10,666 | 10,389 | | Income Before Tax | (46,146) | (94,690) | (59,476) | (310,005) | | Income Tax Expense | (177) | 17 | 16 | (641) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (45,969) | (94,707) | (59,492) | (309,364) | | | Non-recurring Events | | Discontinued Operations | (1,575) | (3,050) | (1,067) | (2,536) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (47,544) | (97,757) | (60,559) | (311,900) | | Preferred Stock And Other Adjustments | (4,388) | (2,855) | (2,682) | (2,682) | | | Net Income Applicable To Common Shares | ($51,932) | ($100,612) | ($63,241) | ($314,582) |
|
0.06% Nasdaq 
Income Statement
